A new study published in August edition of Clinical Pharmacology & Therapeutics suggests that taking folic acid multivitamins during pregnancy may help prevent common childhood cancers, according to a report from Healthnotes Newswire. An analysis of seven studies found that the children of mothers who used multivitamins containing folic acid during pregnancy had an 18% lower chance of developing brain tumors, 47% less risk for neuroblastoma, and 36% decreased risk for leukemia versus those whose mothers did not take multivitamins during pregnancy. According to the article, which is available at www.supplementinfo.org, the authors estimate that supplmentation with folic acid-containing multivitamins during pregnancy could prevent 900 cases of childhood leukemia per year in the USA.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze